As of 2025-05-16, the Fair Value of Cyclo Therapeutics Inc (CYTH) is -3.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.72 USD, the upside of Cyclo Therapeutics Inc is -622.71%.
With the market price of 0.72 USD and our fair value calculation, Cyclo Therapeutics Inc (CYTH) is not a good investment. Investing in CYTH stocks now will result in a potential loss of 622.71%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -7.53 | -8.94 | -14.29 | -15.45 | -20.06 | -13.25 |
| YoY growth | -76.76% | -18.73% | -59.84% | -8.12% | -29.82% | -38.65% |
| Market Cap (mil) | 23.72 |
| P/E | |
| Forward P/E |
| EPS | -0.75 |
| Avg earnings growth rate | -38.65% |
| TTM earnings | -24.80 |